PMI New Jersey Chapter
PMINJ 2004 March Meeting

23 March 2004 - Hanover - Marriott


PDP Information

Program Number: C020-16032004
Enhancing Innovation & Productivity in the Pharmaceutical Industry
Category Type: 3 
Subject Areas 
Knowledge: 10 
Process: 06
Application/Specific Interest Groups: 14 
Activity Sponsor: PMINJ Chapter (C020)
PDUs: - 1.5
Leadership - 0.0
Strategic - 0.0
Technical - 1.5


The pharmaceutical industry is developing groundbreaking drugs that promise to substantially improve patient wellness and quality of life. There are substantial challenges in managing the complexity, cost and cycle time for new drug programs and result in major obstacles to the industry as evidenced by recent declines in pharmaceutical productivity. The presentation outlined elements responsible for the current issues which global cross-functional project teams and organizations must address. Dr. Giesing shared current environmental and operational challenges such as increased disease and technology complexity, escalating product price and lifecycle pressures, R&D pipeline attrition, and effective project risk and cost management. Dr. Giesing also discussed the best practices used to address these challenges such as multi-component optimization, global project plan design and optimization, continuous process improvement, and leading edge approaches to new operations support systems. 

 ericEric Davidson provided a demonstration of the GLOWS Project Tracking system that was developed to assist with the many global projects managed by Aventis.. 



Dr. Dennis Giesing, Senior Vice President, Aventis Phamaceuticals

Dr. Dennis Giesing is Sr. VP, Lead Optimization at Aventis Pharmaceuticals Inc and oversees translational research programs directed toward converting discovery stage candidates into late stage clinical products.  His organization has locations in Germany, France, Japan and Bridgewater, NJ.


© 2021 PMINJ
powered by